Secure shopping
Healthcare and pharma
The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.
The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.
The SEA region has had an admirable record in improving its record against infectious diseases over the nearly three decades from 1990 to 2019. The region’s rapid economic growth relative to the rest of the world has contributed to ...
View more details
Indonesia’s pharmaceuticals and healthcare sector is one of the fastest-growing in the ASEAN region. The Indonesian government has prioritised widening healthcare access and increasing the healthcare system’s capacity since 2014. However, ...
View more details
Malaysia has one of the ASEAN region’s most developed pharmaceuticals and healthcare sectors. Malaysia has a two-tiered system in which the government, under the Ministry of Health, operates healthcare facilities and regulates medical practice ...
View more details
Latin America was among the hardest-hit regions by the COVID-19 pandemic. The novel coronavirus entered the region at a bad time. The commodities boom at end of the 2000s combined with several local crises afterwards have hurt badly the public ...
View more details
Although Thailand’s pharmaceuticals and healthcare sector has developed considerably over the past few decades, there is still considerable runway for further growth. Thailand stands out amongst emerging market countries for offering universal ...
View more details
Colombia was the fourth-largest pharmaceutical market in Latin America in terms of sales volume in 2019, with a large and growing population, a universal but underfunded social security health insurance system, and a small but rapidly ...
View more details
Brazil was one of the hardest-hit nations by the COVID-19 pandemic on a global scale, ranking among the top three countries with the highest number of cases and deaths from the novel coronavirus. Brazil’s pharmaceutical industry, ...
View more details
Mexico is the second-largest pharmaceutical market in Latin America, after Brazil, with retail drug sales of USD 7.3bn in 2019. The country has a growing and ageing population, multiple but underfunded state-run health insurance systems, ...
View more details
Argentina is the third-largest pharmaceutical market in Latin America, with retail drug sales of USD 4.7bn in 2019. The country has a large and ageing population, a relatively developed public health system, and a small but consolidated ...
View more details
In a Latin American context, Chile is not a particularly large pharmaceutical and healthcare market, since its population is relatively small and healthy in terms of incidence of communicable diseases. However, the country’s changing ...
View more details